Day: February 10, 2026

      Monthly Highlights       Increased self-mining hashrate to 63.2 EH/s on continued deployment of SEALMINERs      Bitcoin production increased 430% year over year to 668 Bitcoin      Launch of NVIDIA GB200 NVL72 infrastructure in Malaysia      First design of Litecoin chip taped out and initial testing surpassed expectations        SINGAPORE, Feb. 10, 2026 (GLOBE NEWSWIRE) — Bitdeer Technologies Group (NASDAQ: BTDR) (“Bitdeer” or the “Company”), a world-leading technology company for Bitcoin mining and AI infrastructure, today announced its unaudited mining and operations updates for January 2026. Operational UpdateSelf-mining: Mined 668 Bitcoins, an increase of approximately 430% year over year. Self-mining hashrate reached 63.2 EH/s. Bitdeer will continue deploying SEALMINER mining rigs for self-mining to continue the...

COMPANY ACCELERATES STRATEGIC PIVOT TO PURE-PLAY ENETERTAINMENT MODEL OVERLAND PARK, KS, Feb. 10, 2026 (GLOBE NEWSWIRE) — Kustom Entertainment, Inc. (Nasdaq: KUST) (“Kustom Entertainment” or the “Company”), a leader in live event production and online ticketing, today announced that its subsidiary, TicketSmarter, Inc. has been named one of the 10 Best Ticket Resale Sites of 2026 by Forbes Advisor. Pursuant to its comprehensive review, Forbes Advisor highlighted TicketSmarter as a Best Resale Site for Tickets, on February 6, 2026, specifically citing the platform’s pricing transparency, competitive seller fees, and industry-leading buyer protections as key differentiators in the $100 billion global live entertainment market. The full article may be found at: https://www.forbes.com/advisor/credit-cards/travel-rewards/best-ticket-resale-sites/ “We...

NEW BRUNSWICK, N.J., Feb. 10, 2026 (GLOBE NEWSWIRE) — Myseum, Inc. (Nasdaq: MYSE) (“Myseum” or the “Company”), a privacy-first social media and technology innovator, today issued a shareholder letter by CEO Darin Myman detailing the Company’s plans for revenue generation, developing Picture Party by Myseum (“Picture Party”) for influencers, continuing the development of its new safe social media technology, and executing on its strategic roadmap for near- and long-term growth. Dear fellow shareholders, The recent launch of Picture Party by Myseum has put us in an ideal position to take advantage of growing concerns about the privacy and safety of traditional social media. Over the next several months we will be launching new features, technology and platforms to use our patented technology to both create recurring revenue streams...

Global Coffee Brand with 10,000+ Stores Worldwide Targets Scalable Expansion in Southeast Asia KUALA LUMPUR, Malaysia, Feb. 10, 2026 (GLOBE NEWSWIRE) — VCI Global Limited (NASDAQ: VCIG) (“VCI Global” or the “Company”) today announced that Reveillon Champ Sdn Bhd (“Reveillon Champ”), a subsidiary of VCI Global’s portfolio company Reveillon Group Limited (“Reveillon Group”), has entered a strategic cooperation with NOWWA Global HK Limited (“NOWWA Coffee”) to develop the Malaysian market. The agreement establishes a platform for potential broader expansion across Southeast Asia. Founded in Shanghai in 2019, NOWWA Coffee has rapidly scaled into a global coffee chain with more than 10,000 stores across over 300 cities worldwide. The brand is recognized for its digital-first operating model, health-focused positioning, and strong engagement...

BETHLEHEM, Pa., Feb. 10, 2026 (GLOBE NEWSWIRE) — OraSure Technologies, Inc. (“OraSure”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its OraQuick™ HIV Self-Test has received a license from Health Canada for use in Canada. The OraQuick™ HIV Self-Test is a point-of-care rapid antibody test. It is Canada’s first oral HIV self-test and detects antibodies for both HIV-1 and HIV-2, enabling individuals to find out their HIV status with a simple oral swab in as little as 20 minutes. The simplicity of the product makes it ideal for testing in a range of locations, including in the privacy of one’s home, at the pharmacy, or at community-based testing events. Data from the Public Health Agency of Canada show there were 1,826 new HIV diagnoses in 2024 (not...

PITTSBURGH, Feb. 10, 2026 (GLOBE NEWSWIRE) — Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) announced today that it will report its fourth quarter and full year 2025 financial results on Tuesday, February 17, 2026, prior to the open of U.S. markets. The Company’s management will also host a conference call and webcast at 8:30 am ET on Tuesday, February 17, 2026, to discuss the financial results and provide a business update. Investors and the general public can access the live webcast at: https://www.webcaster5.com/Webcast/Page/3018/53598. For those unable to listen to the live webcast, a replay will be available for at least 30 days on the Investors section of the Company’s website at www.krystalbio.com. About Krystal Biotech, Inc.Krystal Biotech, Inc. (NASDAQ: KRYS) is a fully integrated, commercial-stage, global biotechnology...

SCOTTSDALE, Ariz., Feb. 10, 2026 (GLOBE NEWSWIRE) — Black Rock Coffee Bar, Inc. (Nasdaq: BRCB) (“Black Rock Coffee Bar”) today announced that the Company plans to host a conference call to discuss its fourth quarter and fiscal year 2025 financial results and provide its fiscal year 2026 outlook on March 3rd, 2026, at 5:00 p.m. Eastern Time. The conference call can be accessed live over the phone by dialing 1-877-704-4453 or for international callers, 1-201-389-0920. A live webcast of the conference call will also be available in the investor relations section of Black Rock Coffee Bar’s website, ir.br.coffee. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13757922. The replay will be...

WALTHAM, Mass. and BOULDER, Colo., Feb. 10, 2026 (GLOBE NEWSWIRE) — Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced multiple upcoming posters highlighting bezuclastinib results from the SUMMIT trial in NonAdvanced Systemic Mastocytosis (NonAdvSM) patients at the 2026 American Academy of Allergy Asthma & Immunology Annual Meeting (AAAAI) being held in Philadelphia, PA, February 27-March 2, 2026. In December 2025, Cogent announced that the company submitted its New Drug Application for bezuclastinib in NonAdvSM to the U.S. Food and Drug Administration. The submission is based on positive clinical data from the SUMMIT pivotal trial and follows the Breakthrough Therapy Designation for bezuclastinib in patients with SSM...

Pre-submission package is a process that facilitates early feedback from the United Kingdom (UK) Medicines and Healthcare Products Regulatory Agency (MHRA), designed to streamline the final approval process and reduce time to market Boca Raton, FL, Feb. 10, 2026 (GLOBE NEWSWIRE) — INmune Bio Inc. (NASDAQ: INMB) (“INmune” or the “Company”), a clinical-stage inflammation and immunology company, today announced a critical step toward the commercialization of CORDStrom™ for the treatment of recessive dystrophic epidermolysis bullosa (RDEB).  The Company has formally submitted its pre-submission package for CORDStrom with the United Kingdom’s Medicines and Healthcare Products Regulatory Agency (MHRA). This early engagement step is designed to solicit targeted scientific, regulatory, and procedural feedback, streamlining the...